These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26827115)

  • 21. β-Cells are not uniform after all-Novel insights into molecular heterogeneity of insulin-secreting cells.
    Avrahami D; Wang YJ; Klochendler A; Dor Y; Glaser B; Kaestner KH
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1(Suppl 1):147-152. PubMed ID: 28880481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development, growth and maintenance of β-cell mass: models are also part of the story.
    Khadra A; Schnell S
    Mol Aspects Med; 2015 Apr; 42():78-90. PubMed ID: 25720614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNAs in Pancreatic β-Cell Physiology.
    Özcan S
    Adv Exp Med Biol; 2015; 887():101-17. PubMed ID: 26662988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes.
    Astorri E; Guglielmi C; Bombardieri M; Alessandri C; Buzzetti R; Maggi D; Valesini G; Pitzalis C; Pozzilli P
    Horm Metab Res; 2010 Dec; 42(13):955-60. PubMed ID: 20972946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes.
    Narendran P; Solomon TP; Kennedy A; Chimen M; Andrews RC
    Diabetologia; 2015 Jan; 58(1):10-8. PubMed ID: 25367458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough.
    Ablamunits V; Sherry NA; Kushner JA; Herold KC
    Ann N Y Acad Sci; 2007 Apr; 1103():19-32. PubMed ID: 17376841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
    Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
    Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes.
    Moin ASM; Butler AE
    Curr Diab Rep; 2019 Aug; 19(9):83. PubMed ID: 31401713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes.
    Lee E; Ryu GR; Ko SH; Ahn YB; Yoon KH; Ha H; Song KH
    Biochem Biophys Res Commun; 2011 Oct; 414(2):397-402. PubMed ID: 21971557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The small RNA miR-375 - a pancreatic islet abundant miRNA with multiple roles in endocrine beta cell function.
    Eliasson L
    Mol Cell Endocrinol; 2017 Nov; 456():95-101. PubMed ID: 28254488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
    Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
    Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis in the pathophysiology of diabetes mellitus.
    Lee SC; Pervaiz S
    Int J Biochem Cell Biol; 2007; 39(3):497-504. PubMed ID: 17074529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development and Analysis of Novel Therapeutic Targets to Improve Pancreatic β-Cell Function in Type 2 Diabetes].
    Kaneko YK
    Yakugaku Zasshi; 2016; 136(12):1623-1629. PubMed ID: 27904096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stem-cell therapy, β-cell- and islet cell-neogenesis: possible treatments of type 1 diabetes in the future?].
    Gerő L
    Orv Hetil; 2016 May; 157(19):740-5. PubMed ID: 27133273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotrophic effect of neurotrophins - Restart of β-cell regeneration in diabetes mellitus.
    Hristova MG
    Med Hypotheses; 2017 Sep; 107():9-11. PubMed ID: 28915971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic hyperplasia after gastric bypass surgery in a GK rat model of non-obese type 2 diabetes.
    Zhou X; Qian B; Ji N; Lui C; Liu Z; Li B; Zhou H; Yan C
    J Endocrinol; 2016 Jan; 228(1):13-23. PubMed ID: 26468390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure.
    Eizirik DL; Pasquali L; Cnop M
    Nat Rev Endocrinol; 2020 Jul; 16(7):349-362. PubMed ID: 32398822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An arduous journey from human pluripotent stem cells to functional pancreatic β cells.
    Loo LSW; Lau HH; Jasmen JB; Lim CS; Teo AKK
    Diabetes Obes Metab; 2018 Jan; 20(1):3-13. PubMed ID: 28474496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.